Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor.

Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM.

J Immunol. 2003 Oct 15;171(8):4340-51.

PMID:
14530359
[PubMed - indexed for MEDLINE]
Free Article
2.

Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Iragavarapu-Charyulu V.

Int J Mol Med. 2008 Jan;21(1):125-34.

PMID:
18097625
[PubMed - indexed for MEDLINE]
3.

Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha.

Charyulu VI, Lopez DM.

Int J Oncol. 2000 Jan;16(1):161-7.

PMID:
10601562
[PubMed - indexed for MEDLINE]
4.

GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Handel-Fernandez ME, Iragavarapu-Charyulu V.

Int J Mol Med. 2007 Jul;20(1):129-36.

PMID:
17549399
[PubMed - indexed for MEDLINE]
5.
6.

Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.

Deryugina EI, Soroceanu L, Strongin AY.

Cancer Res. 2002 Jan 15;62(2):580-8.

PMID:
11809713
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE.

Int Immunopharmacol. 2009 Jul;9(7-8):937-48. doi: 10.1016/j.intimp.2009.03.021. Epub 2009 Apr 9.

PMID:
19362167
[PubMed - indexed for MEDLINE]
9.
10.

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.

Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, Solheim JC, Singh RK, Hoke TA, Talmadge JE.

Cancer Immunol Immunother. 2010 Jan;59(1):47-62. doi: 10.1007/s00262-009-0719-2. Epub 2009 May 18.

PMID:
19449184
[PubMed - indexed for MEDLINE]
11.

The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.

Owen JL, Lopez DM, Grosso JF, Guthrie KM, Herbert LM, Torroella-Kouri M, Iragavarapu-Charyulu V.

Cell Immunol. 2005 Jun;235(2):122-35. Epub 2005 Oct 21.

PMID:
16243300
[PubMed - indexed for MEDLINE]
12.

Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.

Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D.

Cancer Res. 2004 Aug 1;64(15):5378-84.

PMID:
15289345
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.

Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.

Clin Cancer Res. 2006 Nov 15;12(22):6808-16.

PMID:
17121902
[PubMed - indexed for MEDLINE]
Free Article
15.

Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice.

Carrio R, Altman NH, Lopez DM.

Cancer Immunol Immunother. 2009 Dec;58(12):2059-72. doi: 10.1007/s00262-009-0714-7. Epub 2009 May 7.

PMID:
19421751
[PubMed - indexed for MEDLINE]
16.

Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.

Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP.

Int J Cancer. 2003 Oct 10;106(6):879-86.

PMID:
12918065
[PubMed - indexed for MEDLINE]
17.

Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.

Donnini S, Monti M, Castagnini C, Solito R, Botta M, Schenone S, Giachetti A, Ziche M.

Int J Cancer. 2007 Mar 1;120(5):995-1004.

PMID:
17131343
[PubMed - indexed for MEDLINE]
18.

Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice.

Sun QL, Charyulu V, Lobo D, Lopez DM.

Anticancer Res. 2002 Jan-Feb;22(1A):91-6.

PMID:
12017339
[PubMed - indexed for MEDLINE]
19.

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.

Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R.

Cancer Res. 2006 Nov 1;66(21):10357-64.

PMID:
17079456
[PubMed - indexed for MEDLINE]
Free Article
20.

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.

Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L.

Cancer Res. 2005 Apr 15;65(8):3193-9.

PMID:
15833850
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk